Why is Onyx Biotec falling/rising?

As of 14-Nov, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 38.50, which represents a decrease of 4.45 or 10.36%. The stock has underperformed its sector by 10.73% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 67.03% compared to the 5-day average. The stock has also shown poor performance over various periods, with a year-to-date decline of 35.29%, indicating ongoing challenges for the company.
In the broader market context, the Sensex has shown a positive return of 1.64% over the past week and 3.04% over the past month, contrasting sharply with Onyx Biotec's declines of 4.11% and 8.33% in the same periods. This suggests that while the overall market is performing well, Onyx Biotec is struggling significantly. The lack of available positive or negative dashboard factors further complicates the situation, as there are no additional insights to explain the stock's recent movement. Overall, the combination of poor performance metrics and declining investor interest is contributing to the stock's downward trajectory.